External News
Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function
Read the Publication ➡
External News
Science in Seattle: BRI Awarded $3.4M NIH R01 Grant to Continue Studying Why Immune Responses are Altered in Those with Down Syndrome
Read more ➡
News
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
Press Release
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
Read More
External News
Islet-homing engineered T regs protect against Type 1 diabetes
Read more ➡
Press Release
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
News
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
Read More
Press Release
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
Read More
External News
Seahawks Rumble on the Ridge tournament kicks off Boeing Classic
Read more ➡
External News
Boeing Classic kids’ events: Learn to golf, or watch the pros (or both)
Read more ➡
Press Release
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
Read More
External News
Science in Seattle: BRI Advances Understanding of the Link between Genetics and Autoimmune Disease Risk
Read more ➡
External News
Exploring autoimmunity's regulatory roots
Read more ➡
External News
The thousands of genetic variants linked to autoimmune disease have been honed down to those most likely to have an effect
Read more ➡Press Release
